About this episode

The episode discusses insights from STAT's Breakthrough Summit West, including biotech challenges and advancements in longevity research.

On this week’s episode of “The Readout LOUD,” the hosts discuss STAT's Breakthrough Summit West, where powerful leaders from health care and science rubbed shoulders. They share some of the juicy conversations and insights, including BridgeBio CEO Neil Kumar's comments that the company is publishing “not the right structures” in their research publications. Listeners also will hear Allison's interview with Joe Betts-LaCroix, CEO of the Sam Altman-backed longevity company Retro Biosciences. Retro is preparing for its first clinical data readout and examining just how much impact AI can have in drug development. The hosts also discuss colleague Damian Garde's article on how China is tearing biotech apart and one self-appointed spokesperson’s strategy.

More episodes of The Readout Loud

• 404: What RevMed's pancreatic cancer drug meant for one patient · June 4, 2026 · 38 min
• 403: Biotech exec Jeremy Levin on the industry's strategic turning point · May 28, 2026 · 47 min
• 401: Makary’s departure and Cassidy’s tenuous Senate seat · May 14, 2026 · 41 min

Explore listener stats, chart rankings, contacts and more on the The Readout Loud podcast page.